Hepatoblastoma With Lung Metastases: Another Cycle of Chemo, or Resection?
Carousel1 min read·Published Nov 2026

Hepatoblastoma With Lung Metastases: Another Cycle of Chemo, or Resection?

Clinical case: 2-year-old with metastatic hepatoblastoma showing partial response to chemotherapy.
Slide explaining that restaging MRI measures tumor size but viability requires separate assessment via serial imaging and AFP.
Slide showing histology images of tumor tissue with pools of blood and inflammation cells after treatment.
Blue slide explaining that slowed tumor shrinkage signals time for surgical planning, not more chemotherapy cycles.
Slide explaining when to transition from chemotherapy to surgical resection in oncology treatment.
Final slide inviting viewers to follow for more pediatric surgery education content from Cincinnati Children's.
1 / 7

Carousel · Nov 2026 · 1 min read

In brief

In brief

Educational carousel covering hepatoblastoma, the most common malignant liver tumor in children, likely part of a clinical teaching series on pediatric liver cancer diagnosis and management.

Written by the GCMD Library team from the carousel.

Slides

7 pages · click to turn to one
Oncology — hepatoblastoma. A social-media carousel made possible by Cincinnati Children's.
The text on each slide
  1. Oncology | Expert-to-Expert | Made possible by Cincinnati Children's | A 2yo with hepatoblastoma has AFP levels >300,000 ng/mL & bilateral lung metastases. On cisplatin and doxorubicin. The liver mass initially shrank on serial MRI, then stalled. | ANOTHER CYCLE OF CHEMO, OR RESECTION? | 1/7
  2. Oncology | Expert-to-Expert | Made possible by Cincinnati Children's | READING THE RESTAGING MRI | THE SCAN MEASURES SIZE. VIABILITY IS A SEPARATE QUESTION. | Tumor response is tracked with serial MRI and AFP. Early on, tumor cell death is accompanied by tumor shrinkage, but this changes partway through induction. | 2/7
  3. Oncology | Expert-to-Expert | Made possible by Cincinnati Children's | WHAT THE SPECIMEN SHOWED | MORE THAN 90% TUMOR DEATH | POOLS OF BLOOD AND INFLAMMATION CELLS | At resection, this tumor appeared as mostly pools of blood and fibrous tissue, with a few scattered pockets of viable cells. | But it still occupies volume. | 3/7
  4. Oncology | Expert-to-Expert | Made possible by Cincinnati Children's | Sarangarajan Ranganathan, MD | Division of Pathology and Laboratory Medicine, Cincinnati Children's | 4/7
  5. Oncology | Expert-to-Expert | Made possible by Cincinnati Children's | THE DECISION | SLOWED TUMOR SHRINKAGE ALONE ISN'T A REASON TO ADD MORE CHEMO CYCLES | Most of the shrinkage comes in the first blocks of induction. | The plateau is your cue to interpret the AFP alongside imaging, and to start planning surgical resection. | 5/7
  6. Oncology | Expert-to-Expert | Made possible by Cincinnati Children's | THE TAKEAWAY | When size plateaus and the AFP is still falling, the mass consists of mostly necrosis and scarring. | Another cycle won't shrink it. That's the point where the planning moves from chemotherapy to resection. | 6/7
  7. Oncology | Expert-to-Expert | Made possible by Cincinnati Children's | FOLLOW FOR MORE PEDIATRIC SURGERY EDUCATION. | 7/7
Intelligent Search· scoped to this carousel · not medical adviceSearch the whole library →
GCMD Library — educational content from recorded physician discussions, not medical advice.